Information Provided By: 
Fly News Breaks for July 13, 2018
TEVA, VRX
Jul 13, 2018 | 12:08 EDT
Evercore ISI analyst Umer Raffat notes that the FDA website shows that a generic version of Valeant's (VRX) Apriso, a top 10 product for the company, has been granted a tentative approval. This approval, which was granted to Teva (TEVA), is the second generic approval for one of the company's top 10 products in the last few days, as a generic Uceris approval was also recently granted, added Raffat in his note to investors. He maintains an In Line rating on Valeant shares.
News For VRX;TEVA From the Last 2 Days
There are no results for your query VRX;TEVA
